Chemical Evaluation of Medical Devices
Chemical Evaluation of Medical Devices, Total:388 items.
The international standard classification for "Chemical Evaluation of Medical Devices" includes: Medical equipment in general , Laboratory medicine , Dental materials , Surgical instruments and materials , Sterilization and disinfection in general , Other medical equipment .
The Chinese standard classification for "Chemical Evaluation of Medical Devices" includes: Medical apparatus and devices in general , Stomatologic device, equipment and material , Public medical equipment .
未注明发布机构
- ANSI/AAMI/ISO TIR10993-19:2006 Biological evaluation of medical devices — Part 19: Physico- chemical, morphological, and topographical characterization of materials
- DIN EN ISO 10993-18 E:2018-09 Biological evaluation of medical devices Part 18: Chemical characterization of medical device materials during risk management (draft)
- DIN EN ISO 7405 E:2017-04 Biocompatibility evaluation of dental medical devices in dentistry (draft)
- ANSI/AAMI/ISO 10993-5:2009(2014) Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- DIN EN ISO 10993-1:1998 Biological evaluation of medical devices – Part 1: Evaluation and testing
- ANSI/AAMI/ISO TIR10993-20:2006 Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices
- DIN EN ISO 10993-1:2003 Biological assessment of medical devices Part 1: Assessment and testing
- ANSI/AAMI/ISO 10993-1:2018 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
- ANSI/AAMI/ISO 10993-2:2006(2010) Biological evaluation of medical devices— Part 2: Animal welfare requirements
- ANSI/AAMI/ISO 10993-11:2017 Biological evaluation of medical devices—Part 11: Tests for systemic toxicity
- ANSI/AAMI/ISO 10993-13:2010(2014) Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
- DIN EN ISO 10993-18:2009 Biological assessment of medical devices
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 16886.5-2017 Biological evaluation of medical devices―Part 5:Tests for in vitro cytotoxicity
- GB/T 16886.11-1997 Biological evaluation of medical devices--Part 11: Tests for systemic toxicity
- GB/T 16886.11-2011 Biological evaluation of medical devices—Part 11:Tests for systemic toxicity
- GB/T 16886.19-2022 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
- GB/Z 16886.22-2022 Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
- GB/T 16886.18-2011 Biological evaluation of medical devices—Part 18:Chemical characterization of materials
- GB/T 16886.19-2011 Biological evaluation of medical devices—Part 19:Physico-chemical,morphological and topographical characterization of materials
- GB/T 16886.20-2015 Biological evaluation of medical devices―Part 20:Principles and methods for immunotoxicology testing of medical devices
- GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2:Animal welfare requirements
- GB/T 16886.1-2001 Biological evaluation of medical devices--Part 1:Evaluation and testing
- GB/T 16886.2-2011 Biological evaluation of medical devices—Part 2:Animal welfare requirements
- GB/T 16886.18-2022 Biological evaluation of medical devices—Part 18: Chemical characterization of medical device materials within a risk management process
- GB/T 16886.5-2003 Biological evaluation of medical devices - Part 5: Test for in vitro cytotoxicity
- GB/T 16886.7-2015 Biological evaluation of medical devices—Part 7: Ethylene oxide sterilization residuals
- GB/T 16886.10-2000 Biological evaluation of medical devices-Part 10:Tests for irritation and sensitization
- GB/T 16886.13-2001 Biogical evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
- GB/T 16886.23-2023 Biological evaluation of medical devices—Part 23: Tests for irritation
- GB/T 16886.1-2011 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
Professional Standard - Medicine
- YY/T 0268-2008 Dentistry - Biological evaluation of medical devices used in dentistry Part1: Evaluation and test
- YY/T 0127.11-2014 Biological evaluation of medical devices used in dentistry―Part 11:Pulp capping test
- YY/T 0127.4-2023 Biological evaluation of medical devices used in dentistry-Part 4: Bone implant test
- YY/T 1295-2015 Biological evaluation of medical devices―Nanomaterial:Endotoxin test
- YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
- YY/T 0127.5-2014 Biological evaluation of medical devices used in dentistry―Part 5:Inhalation toxicity test
- YY/T 1815-2022 Biological evaluation of medical devices-Application for the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- YY/T 1266-2015 Evaluation of materials of medical device subject to hydrogen peroxide sterilization
Group Standards of the People's Republic of China
- T/CSYLQX 0001-2021 Standards for Credit Evaluation of Medical Device Operating Enterprises
- T/CAMDI 033-2020 Guide for biological evaluation of packaging materials for medical devices
- T/SXS 129-2023 Medical device enterprise management credit evaluation standards
- T/CAMDI 034-2020 Biological evaluation of medical devices Medical catheter with hydrophilic polymer coating:Sample preparation
- T/CSBME 009-2019 Quality evaluation method of cybersecurity in medical devices
Jiangsu Provincial Standard of the People's Republic of China
- DB3212/T 1065-2021 Standards for Quality Evaluation of Medical Devices Used in Medical Institutions
国家食品药品监督管理局
- YY/T 1512-2017 Biological evaluation of medical devices—Guidance on the conduct of biological evaluation within a risk management process
- YY/T 1532-2017 Biological evaluation of medical devices—Nanomaterials—Hemolysis test
中华人民共和国国家质量监督检验检疫总局、中国国家标准化管理委员会
- GB/T 16886.13-2017 Biological evaluation of medical devices-Part 13:Identification and quantification of degradation products from polymeric medical devices
国家市场监督管理总局、中国国家标准化管理委员会
- GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
- GB/T 16886.11-2021 Biological evaluation of medical devices—Part 11:Tests for systemic toxicity
Professional Standard - Agriculture
- GB/T 16886.10-2024 Biological evaluation of medical devices—Part 10:Tests for skin sensitization
Henan Provincial Standard of the People's Republic of China
- DB41/T 2320-2022 Medical device adverse event reporting and evaluation specification
International Organization for Standardization (ISO)
- ISO/CD 10993-1.2:2023 Biological evaluation of medical devices
- ISO 10993-18:2020 Biological evaluation of medical devices — Part 18: Chemical characterization of medical device materials within a risk management process
- ISO 10993-1:1997 Biological evaluation of medical devices - Part 1: Evaluation and testing
- ISO 10993-1:2003 Biological evaluation of medical devices - Part 1: Evaluation and testing
- ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
- ISO/TR 15499:2016 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
- ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
- ISO 10993-13:1998 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
- ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
- ISO 10993-2:2022 Biological evaluation of medical devices — Part 2: Animal welfare requirements
- ISO 10993-2:1992 Biological evaluation of medical devices; part 2: animal welfare requirements
- ISO 10993-10:2021 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
- ISO 10993-2:2006 Biological evaluation of medical devices - Part 2: Animal welfare requirements
- ISO 10993-11:1993 Biological evaluation of medical devices; part 11: tests for systemic toxicity
- ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
- ISO/TR 15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
- ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices — Part 1: General requirements
- ISO 10993-14:2001 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
- ISO 10993-1:2009 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- ISO 10993-1:2009/Cor 11:2010 Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
- ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
- ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
SCC
- BS EN ISO 10993-18:2005 Biological evaluation of medical devices-Chemical characterization of materials
- BS EN ISO 10993-18:2009 Biological evaluation of medical devices-Chemical characterization of materials
- BS EN ISO 10993-1:1998 Biological evaluation of medical devices-Evaluation and testing
- DANSK DS/ISO 10993-17:2023 Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents
- AAMI/ISO 10993-1:2003 Biological Evaluation of Medical Devices Part 1: Evaluation and Testing
- CAN/CSA-ISO 10993-1-01:2001 Biological evaluation of medical devices - Part 1: Evaluation and Testing
- DANSK DS/EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
- BS EN 30993-1:1994 Biological evaluation of medical devices-Guidance on selection of tests
- BS EN ISO 10993-11:1996 Biological evaluation of medical devices-Tests for systemic toxicity
- BS EN ISO 10993-11:2006 Biological evaluation of medical devices-Tests for systemic toxicity
- BS EN ISO 10993-2:1998 Biological evaluation of medical devices-Animal welfare requirements
- DANSK DS/ISO/TS 10993-20:2006 Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices
- SN-ISO/TS 10993-20:2006 Biological evaluation of medical devices — Part 20: Principles and methods for immunotoxicology testing of medical devices
- AS ISO 10993.10:2002 Biological evaluation of medical devices - Tests for irritation and sensitization
- BS EN ISO 10993-13:2009 Biological evaluation of medical devices-Identification and quantification of degradation products from polymeric medical devices
- BS PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- DANSK DS/ISO/TS 21726:2019 Biological evaluation of medical devices – Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- DIN EN ISO 10993-17 E:2021 Draft Document – Biological evaluation of medical devices – Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021
- UNE-EN ISO 10993-1:2004 Biological evaluation of medical devices - Part 1: Evaluation and testing (ISO 10993-1:2003)
- BS PD ISO/TR 10993-22:2017 Biological evaluation of medical devices-Guidance on nanomaterials
- BS DD ISO/TS 10993-19:2006 Biological evaluation of medical devices-Physico-chemical, morphological and topographical characterization of materials
- BS PD ISO/TS 10993-19:2020 Biological evaluation of medical devices-Physico-chemical, morphological and topographical characterization of materials
- NS-EN ISO 10993-1:1997 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:1997)
- 08/30156451 DC BS EN ISO 10993-13. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
- UNE-EN ISO 10993-13:2000 BIOLOGICAL EVALUATION OF MEDICAL DEVICES. PART 13: IDENTIFICATION AND QUANTIFICATION OF DEGRADATION PRODUCTS FROM POLYMERIC MEDICAL DEVICES (ISO 10993-13:1998)
- DANSK DS/EN 13612/AC:2003 Performance evaluation of in vitro diagnostic medical devices
- NS-EN ISO 10993-1:2003 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:2003)
- NS-EN ISO 10993-1:2009 Biological evaluation of medical devices — Part 1: Evaluation and testing (ISO 10993-1:2003)
- BS EN ISO 10993-12:2009 Biological evaluation of medical devices-Sample preparation and reference materials
- AS ISO 10993.12:2002 Biological evaluation of medical devices - Sample preparation and reference materials
- BS EN 30993-6:1995 Biological evaluation of medical devices-Tests for local effects after implantation
- NS-EN ISO 10993-18:2005 Biological evaluation of medical devices — Part 18: Chemical characterization of materials (ISO 10993-18:2005)
- DANSK DS/EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices
- NS-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices
- NS-EN ISO 10993-18:2009 Biological evaluation of medical devices — Part 18: Chemical characterization of materials (ISO 10993-18:2005)
- BS EN ISO 10993-7:1996 Biological evaluation of medical devices-Ethylene oxide sterilization residuals
- BS EN ISO 10993-12:1997 Biological evaluation of medical devices-Sample preparation and reference materials
- BS EN ISO 10993-10:1996 Biological evaluation of medical devices-Tests for irritation and sensitization
- UNE-EN ISO 10993-18:2006 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
- BS EN ISO 10993-6:2007 Biological evaluation of medical devices-Tests for local effects after implantation
- DANSK DS/EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
- AAMI/ISO 10993-16:1997(R2009) Biological evaluation of medical devices Part 16: Toxicokinetic study design for degradation products and leachables from medical devices
- DIN EN ISO 10993-1/A1 E:2009 Draft Document - Biological evaluation of medical devices - Part 1: Evaluation and testing (ISO 10993-1:2003); English version FprEN ISO 10993-1:2009, Amendment 1
- CAN/CSA-ISO 10993-13-00:2000 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices
- CAN/CSA-ISO 10993.2-1997(R2006) Biological evaluation of medical devices - Part 2: Animal welfare requirements
- CAN/CSA-ISO 10993.11-1998(R2002) Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guidance on the conduct of biological evaluation within a risk management process
- BS 5736-8:1984 Evaluation of medical devices for biological hazards-Method of test for skin irritation of solid medical devices
- CAN/CSA-ISO 10993.11-1998(C2002) Biological evaluation of medical devices - Part 11: Systemic toxicity testing
- AAMI/ISO 10993-11:2017 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- CAN/CSA-ISO 10993-1-98:1998 Biological evaluation of medical devices - Part 1: Guidelines for the selection of tests
- DANSK DS/ISO 10993-10:2023 Biological evaluation of medical devices – Part 10: Tests for skin sensitization
- AAMI/ISO 10993-2:1993 Biological Evaluation of Medical Devices - Part 2: Animal Protection Requirements
- BS PD ISO/TR 10993-55:2023 Biological evaluation of medical devices-Interlaboratory study on cytotoxicity
- DANSK DS/ISO 10993-2:2022 Biological evaluation of medical devices – Part 2: Animal welfare requirements
- DANSK DS/EN ISO 10993-11:2009 Biological evaluation of medical devices – Part 11: Tests for systemic toxicity
- BS PD ISO/TR 10993-33:2015 Biological evaluation of medical devices-Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
- DANSK DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
- SN-ISO/TR 15499:2012 Biological evaluation of medical devices — Guidance on the conduct of biological evaluation within a risk management process
- AENOR UNE-EN 13612/AC:1970 Performance evaluation of in vitro diagnostic medical devices.
- AENOR UNE-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices.
- DANSK DS/ISO/TR 15499:2016 Biological evaluation of medical devices – Guidance on the conduct of biological evaluation within a risk management process
- CAN/CSA-ISO 10993.2-1997(C2006) Biological evaluation of medical devices - Part 2: Animal protection requirements
- BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
- SN-ISO/TS 10993-19:2020 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
- BS 5736-7:1983 Evaluation of medical devices for biological hazards-Method of test for skin irritation of extracts from medical devices
- SN-ISO/TS 10993-19:2006 Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials
- DANSK DS/EN ISO 10993-2:2006 Biological evaluation of medical devices – Part 2: Animal welfare requirements
- ADA 41-2020 Evaluation of Biocompatibility of Medical Devices Used in Dentistry
- DANSK DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
- BS 5736-4:1981 Evaluation of medical devices for biological hazards-Method of test for intracutaneous reactivity of extracts from medical devices
- ADA 41-2015 Evaluation of Biocompatibility of Medical Devices Used in Dentistry
- DANSK DS/ISO/TS 10993-19:2020 Biological evaluation of medical devices – Part 19: Physico-chemical, morphological and topographical characterization of materials
- NS-EN ISO 10993-13:1998 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymers medical devices (ISO 10993-13:1998)
- AAMI/ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for In Vitro Cytotoxicity
- DANSK DS/ISO 10993-18/AMD 1:2020 Biologisk vurdering af medicinsk udstyr – Del 18: Kemisk karakterisering af materialer til medicinsk udstyr inden for rammerne af en risikostyringsproces
- DANSK DS/ISO 10993-18:2020 Biologisk vurdering af medicinsk udstyr – Del 18: Kemisk karakterisering af materialer til medicinsk udstyr inden for rammerne af en risikostyringsproces
- BS 5736-10:1988 Evaluation of medical devices for biological hazards-Method of test for toxicity to cells in culture of extracts from medical devices
- AS ISO 10993.4:2002 Biological evaluation of medical devices - Selection of tests for interactions with blood
- BS EN 30993-4:1994 Biological evaluation of medical devices-Selection of tests for interactions with blood
- BS 5736-1:1989 Evaluation of medical devices for biological hazards-Guide for the selection of biological methods of test
- NS-EN ISO 10993-13:2009 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
- CAN/CSA-ISO 10993-5-01:2001 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- BS 5736-1:1979 Evaluation of medical devices for biological hazards-Guide for the selection of biological methods of test
- DANSK DS/EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- AENOR UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
- NS-EN ISO 10993-13:2010 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
- DANSK DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
- DANSK DS/ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
- UNE-EN ISO 10993-13:2009 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
- AAMI/ISO TIR10993-19:2006 Biological evaluation of medical devices - Part 19: Physio-chemical, morphological and topographical characterization of materials [Historical]
- CAN/CSA-ISO 10993.7-1998(R2007) Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals
- BS 5736-3:1981 Evaluation of medical devices for biological hazards-Method of test for systemic toxicity; assessment of acute toxicity of extracts from medical devices
- BS PD ISO/TR 15499:2012 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
British Standards Institution (BSI)
- BS EN ISO 10993-17:2023 Biological evaluation of medical devices - Toxicological risk assessment of medical device constituents
- DD ISO/TS 10993-20:2006 Biological evaluation of medical devices. Principles and methods for immunotoxicology testing of medical devices
- 21/30379304 DC BS EN ISO 10993-17. Biological evaluation of medical devices - Part 17. Toxicological risk assessment of medical device constituents
- BS EN ISO 10993-2:2022 Biological evaluation of medical devices - Animal welfare requirements
- PD ISO/TR 10993-22:2017 Biological evaluation of medical devices. Guidance on nanomaterials
- BS EN ISO 10993-13:2010 Biological evaluation of medical devices. Part 13: Identification and quantification of degradation products from polymeric medical devices
- BS EN ISO 10993-10:2023 Biological evaluation of medical devices. Tests for skin sensitization
- PD ISO/TS 21726:2019 Biological evaluation of medical devices. Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- 18/30358832 DC BS EN ISO 10993-18. Biological evaluation of medical devices. Part 18. Chemical characterization of medical device materials within a risk management process
- PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
- BS PD ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices. General requirements
- PD ISO/TS 10993-19:2020 Biological evaluation of medical devices. Physico-chemical, morphological and topographical characterization of materials
- 24/30482502 DC BS EN ISO 10993-17:2023/Amd 1 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents — Amendment
- BS EN ISO 10993-18:2020+A1:2023 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
- ISO 10993-18:2020/Amd.1:2022 Biological evaluation of medical devices - Chemical characterization of medical device materials within a risk management process
- BS EN ISO 10993-1:2003 Biological evaluation of medical devices - Evaluation and testing
- BS EN ISO 10993-12:2021 Biological evaluation of medical devices. Sample preparation and reference materials
- BS EN 29073-3:1992 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
- BS EN ISO 10993-7:2008+A1:2022 Biological evaluation of medical devices. Ethylene oxide sterilization residuals
- BS EN ISO 10993-12:2012 Biological evaluation of medical devices. Sample preparation and reference materials
- BS EN ISO 10993-11:2018(2022) Biological evaluation of medical devices Part 11 : Tests for systemic toxicity
- BS EN ISO 10993-6:2016 Biological evaluation of medical devices. Tests for local effects after implantation
- BS EN ISO 10993-9:2021 Biological evaluation of medical devices. Framework for identification and quantification of potential degradation products
- BS EN ISO 10993-18:2020 Biological evaluation of medical devices Part 18 : Chemical characterization of medical device materials within a risk management process
- BS EN ISO 10993-11:2018 Biological evaluation of medical devices. Tests for systemic toxicity
- BS EN ISO 10993-6:2009 Biological evaluation of medical devices. Tests for local effects after implantation
- BS PD ISO/TR 15499:2016 Biological evaluation of medical devices. Guidance on the conduct of biological evaluation within a risk management process
- BS EN ISO 10993-1:2020 Biological evaluation of medical devices. Evaluation and testing within a risk management process
- PD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices. Guidance for absorbable implants
- PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
- 24/30453873 DC BS EN ISO 10993-6 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation
RU-GOST R
- GOST ISO 10993-1-2011 Medical devices. Biological evaluation of medical devices. Part 1. Evaluation and testing
- GOST ISO 10993-18-2011 Medical devices. Biological evaluation of medical devices. Part 18. Chemical characterization of materials
- GOST ISO 10993-13-2011 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
- GOST ISO 10993-11-2011 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic toxicity
- GOST R ISO 10993-11-1999 Medical devices. Biological evaluation of medical devices. Part 11. Tests for systemic to xicity
- GOST ISO/TS 10993-20-2011 Medical devices. Biological evaluation of medical devices. Part 20. Principles and methods for immunotoxicology testing of medical devices
- GOST ISO 10993-14-2011 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
- GOST R ISO 10993-14-2001 Medical devices. Biological evaluation of medical devices. Part 14. Identification and quantification of degradation products from ceramics
- GOST R ISO 10993-10-1999 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and sensitization
- GOST ISO/TS 10993-19-2011 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
- GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
- GOST ISO 10993-7-2016 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
- GOST ISO 10993-13-2016 Medical devices. Biological evaluation of medical devices. Part 13. Identification and quantification of degradation products from polymeric medical devices
- GOST ISO 10993-9-2011 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
- GOST ISO 10993-7-2011 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
- GOST ISO 10993-6-2011 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
- GOST ISO 10993-12-2011 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and control materials
- GOST R ISO 10993-6-1999 Medical devices. Biological evaluation of medical devices. Part 6. Tests for local effects after implantation
- GOST R ISO 10993-12-1999 Medical devices. Biological evaluation of medical devices. Part 12. Sample preparation and reference materials
- GOST ISO 10993-15-2011 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
- GOST R ISO 10993-15-2001 Medical devices. Biological evaluation of medical devices. Part 15. Identification and quantification of degradation products from metals and alloys
- GOST ISO 10993-10-2011 Medical devices. Biological evaluation of medical devices. Part 10. Tests for irritation and delayed-type hypersensitivity
- GOST ISO 10993-17-2011 Medical devices. Biological evaluation of medical devices. Part 17. Establishment of allowable limits for leachable substances
- GOST ISO 10993-4-2011 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
- GOST ISO 10993-9-2015 Medical devices. Biological evaluation of medical devices. Part 9. Framework for identification and quantification of potential degradation products
- GOST R ISO 10993.7-1999 Medical devices. Biological evaluation of medical devices. Part 7. Ethylene oxide sterilization residuals
- GOST ISO 10993-16-2016 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
- GOST ISO 10993-3-2011 Medical devices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicity
- GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
- GOST ISO 10993-16-2011 Medical devices. Biological evaluation of medical devices. Part 16. Toxicokinetic study design for degradation products and leachables
- GOST R ISO 10993.4-1999 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
Standard Association of Australia (SAA)
- ISO 10993-17:2023 Biological evaluation of medical devices — Part 17: Toxicological risk assessment of medical device constituents
- AS ISO 10993.11:2002/Amdt 1:2005 Biological evaluation of medical devices Systemic toxicity testing
- AS ISO 10993.17:2004 Biological evaluation of medical devices - Establishment of allowable limits for leachable substances
German Institute for Standardization
- DIN EN ISO 10993-17:2021-12 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/DIS 10993-17:2021); German and English version prEN ISO 10993-17:2021 / Note: Date of issue 2021-11-12*Intended as replacement for DIN...
- DIN EN ISO 10993-17:2024-02 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023); German version EN ISO 10993-17:2023
- DIN EN 13612:2002-08 Performance evaluation of in vitro diagnostic medical devices; German version EN 13612:2002, German and English texts
- DIN EN ISO 10993-2:2023-02 Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022); German version EN ISO 10993-2:2022
- DIN EN ISO 10993-11:2018-09 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017); German version EN ISO 10993-11:2018
- DIN EN ISO 10993-10:2023-04 Biological evaluation of medical devices - Part 10: Tests for skin sensitization (ISO 10993-10:2021); German version EN ISO 10993-10:2023
- DIN EN ISO 10993-18/A1:2021-10 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021); German and English version...
- DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
- DIN EN ISO 10993-13:2010-11 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010); German version EN ISO 10993-13:2010
- DIN EN ISO 10993-1:2010 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management system (ISO 10993-1:2009); German version EN ISO 10993-1:2009
VN-TCVN
- TCVN 7391-18-2007 Biological evaluation of medical devices.Part 18: Chemical characterization of materials
- TCVN 7391-1-2004 Biological evaluation of medical devices.Part 1: Evaluation and testing
- TCVN 7391-2-2005 Biological evaluation of medical devices.Part 2: Animal welfare requirements
- TCVN 7391-11-2007 Biological evaluation of medical devices.Part 11: Tests for systemic toxicity
- TCVN 7391-14-2007 Biological evaluation of medical devices.Part 14: Identification and quantification of degradation products from ceramics
- TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
- TCVN 7391-7-2004 Biological evaluation of medial devices.Part 7: Etylen oxide sterilization residuals
TH-TISI
- TIS 2395.18-2008 Biological evaluation of medical devices.part 18: chemical characterization of materials
- TIS 2395.1-2008 Biological evaluation of medical devices.part 1: evaluation and testing
- TIS 2395.13-2008 Biological evaluation of medical devices.part 13: identification and quantification of degradation products from polymeric medical devices
- TIS 2395.11-2008 Biological evaluation of medical devices.part 11: tests for systemic toxicity
- TIS 2395.2-2008 Biological evaluation of medical devices.part 2: animal welfare requirements
- TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
- TIS 2395.6-2008 Biological evaluation of medical devices.part 6: tests for local effects after implantation
- TIS 2395.12-2008 Biological evaluation of medical devices.part 12: sample preparation and reference materials
Korean Agency for Technology and Standards (KATS)
- KS P ISO 10993-18:2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
- KS P ISO 10993-18-2009(2019) Biological evaluation of medical devices-Part 18:Chemical characterization of materials
- KS P ISO 10993-20-2019 Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
- KS P ISO 10993-20-2009(2019) Biological evaluation of medical devices-Part 20:Principles and methods for immunotoxicology testing of medical devices
- KS P ISO TS 21726-2023 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- KS P ISO TS 20993-2020 Biological evaluation of medical devices-Guidance on a risk-management process
- KS P ISO TS 20993-2009(2014) Biological evaluation of medical devices-Guidance on a risk-management process
- KS P ISO 10993-13-2023 Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
- KS P ISO 10993-2-2010(2021) Biological evaluation of medical devices-Part 2:Animal welfare requirements
- KS P ISO TR 15499-2021 Biological evaluation of medical devices — Guidance on the conduct of biological evaluation within a risk management process
- KS P ISO 10993-11-2007(2017) Biological evaluation of medical devices-Part 11:Tests for systemic toxicity
- KS P ISO 10993-2-2010(2016) Biological evaluation of medical devices-Part 2:Animal welfare requirements
- KS P ISO 10993-2-2021 Biological evaluation of medical devices-Part 2:Animal welfare requirements
- KS P ISO 10993-19-2009(2019) Biological evaluation of medical devices-Part 19:Physico-chemical, morphological and topographical characterization of materials
- KS P ISO TS 10993-19:2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
- KS P ISO 10993-11:2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
- KS P ISO 10993-5-2023 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS P ISO TS 37137-1-2023 Biological evaluation of absorbable medical devices — Part 1: General requirements
GSO
- GSO ISO 10993-18:2016 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
- BH GSO ISO 10993-18:2017 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
- OS GSO ISO 10993-18:2016 Biological evaluation of medical devices -- Part 18: Chemical characterization of materials
- GSO ISO/TS 10993-20:2016 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
- OS GSO ISO/TS 10993-20:2016 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
- BH GSO ISO/TS 10993-20:2017 Biological evaluation of medical devices -- Part 20: Principles and methods for immunotoxicology testing of medical devices
- GSO ISO/TS 21726:2021 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- BH GSO ISO/TS 21726:2022 Biological evaluation of medical devices — Application of the threshold of toxicological concern (TTC) for assessing biocompatibility of medical device constituents
- GSO ISO 10993-23:2024 Biological evaluation of medical devices — Part 23: Tests for irritation
- OS GSO ISO/TR 15499:2016 Biological evaluation of medical devices -- Guidance on the conduct of biological evaluation within a risk management process
- GSO ISO/TR 15499:2016 Biological evaluation of medical devices -- Guidance on the conduct of biological evaluation within a risk management process
- OS GSO ISO 10993-13:2016 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
- BH GSO ISO 10993-13:2017 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
- GSO ISO 10993-13:2016 Biological evaluation of medical devices -- Part 13: Identification and quantification of degradation products from polymeric medical devices
- GSO ISO 10993-11:2015 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
- OS GSO ISO/TS 10993-19:2016 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
- GSO ISO/TR 10993-22:2021 Biological evaluation of medical devices — Part 22: Guidance on nanomaterials
- BH GSO ISO 10993-2:2017 Biological evaluation of medical devices -- Part 2: Animal welfare requirements
- OS GSO ISO 10993-11:2015 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
- BH GSO ISO/TR 10993-22:2022 Biological evaluation of medical devices — Part 22: Guidance on nanomaterials
- BH GSO ISO 10993-11:2017 Biological evaluation of medical devices -- Part 11: Tests for systemic toxicity
- GSO ISO/TS 10993-19:2016 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
- BH GSO ISO/TS 10993-19:2017 Biological evaluation of medical devices -- Part 19: Physico-chemical, morphological and topographical characterization of materials
- GSO ISO/TR 37137:2024 Cardiovascular biological evaluation of medical devices — Guidance for absorbable implants
- BH GSO ISO/TS 37137-1:2023 Biological evaluation of absorbable medical devices — Part 1: General requirements
- BH GSO ISO 10993-5:2017 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
- GSO ISO 10993-5:2015 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
- GSO ISO/TS 37137-1:2023 Biological evaluation of absorbable medical devices — Part 1: General requirements
IT-UNI
- UNI EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process
- UNI EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation
- UNI EN ISO 10993-1:2021 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
KR-KS
- KS P ISO 10993-18-2021 Biological evaluation of medical devices —Part 18: Chemical characterization of medical device materials within a risk management process
- KS P ISO 10993-13-2018(2023) Biological evaluation of medical devices — Part 13: Identification and quantification of degradation products from polymeric medical devices
- KS P ISO 10993-23-2022 Biological evaluation of medical devices — Part 23: Tests for irritation
- KS P ISO 10993-10-2022 Biological evaluation of medical devices — Part 10: Tests for skin sensitization
- KS P ISO 10993-11-2021 Biological evaluation of medical devices —Part 11: Tests for systemic toxicity
- KS P ISO TS 10993-19-2021 Biological evaluation of medical devices —Part 19: Physico-chemical, morphological and topographical characterization of materials
- KS P ISO 10993-5-2018(2023) Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS P ISO 10993-6-2018(2023) Biological evaluation of medical devices — Part 6: Tests for local effects after implantation
Association Francaise de Normalisation
- NF S99-501-18*NF EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18 : chemical characterization of medical device materials within a risk management process
- NF S99-501:1998 Biological evaluation of medical devices. Part 1 : evaluation and testing.
- NF EN ISO 10993-23:2021 Evaluation biologique des dispositifs médicaux - Partie 23 : essais d'irritation
- NF S99-501-23*NF EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23 : tests for irritation
- NF EN ISO 10993-13:2010 Biological assessment of medical devices - Part 13: identification and quantification of degradation products of polymer-based medical devices
- NF EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices
- NF S99-501-13*NF EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13 : identification and quantification of degradation products from polymeric medical devices
- NF EN ISO 10993-10:2023 Biological evaluation of medical devices - Part 10: skin sensitization testing
- NF EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: systemic toxicity testing
- XP ISO/TS 10993-19:2022 Évaluation biologique des dispositifs médicaux - Partie 19 : caractérisations physicochimique, morphologique et topographique des matériaux
- NF EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: chemical characterization of medical device materials within a risk management process
- NF S99-501-11:2009 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity.
- FD ISO/TR 10993-22:2017 Biological evaluation of medical devices - Part 22: guidance on nanomaterials
- NF S99-501-11*NF EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11 : tests for systemic toxicity
- FD S99-501-22*FD ISO/TR 10993-22:2017 Biological evaluation of medical devices - Part 22 : guidance on nanomaterials
- NF EN ISO 10993-2:2022 Biological evaluation of medical devices - Part 2: Animal protection requirements
- FD S99-516*FD ISO/TR 37137:2014 Cardiovascular biological evaluation of medical devices - Guidance for absorbable implants
- NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5: testing for in vitro cytotoxicity
- NF S99-518:2005 Biological evaluation of medical devices - Part 18 : chemical characterization of materials.
Japanese Industrial Standards Committee (JISC)
- JIS T 0993-1:2005 Biological evaluation of medical devices -- Part 1: Evaluation and testing
- JIS T 0993-1:2012 Biological evaluation of medical devices -- Part 1: Evaluation and testing within a risk management process
CEN - European Committee for Standardization
- EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
- EN ISO 10993-18:2005 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
- EN ISO 10993-11:2006 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- EN ISO 10993-11:2009 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- EN ISO 10993-14:2009 Biological evaluation of medical devices - Part 14: Identification and quantification of degradation products from ceramics
- EN ISO 10993-14:2001 Biological Evaluation of Medical Devices - Part 14: Identification and Quantification of Degradation Products from Ceramics
DIN
- DIN EN ISO 10993-17:2024 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023)
- DIN EN ISO 10993-13:1999 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
- DIN EN ISO 10993-13:2009 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:1998)
European Committee for Standardization (CEN)
- EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
- FprEN ISO 10993-17 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO/FDIS 10993-17:2023)
- EN ISO 10993-17:2023 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023)
- EN ISO 10993-18:2020/prA1 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
- EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
- EN ISO 10993-18:2020/prA1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/DAM 1:2021)
- EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- EN ISO 10993-11:1995 Biological Evaluation of Medical Devices - Part 11: Tests for Systemic Toxicity (ISO 10993-11 : 1993)
GOST
- GOST R ISO/TS 10993-20-2009 Medical devices. Biological evaluation of medical devices. Part 20. Principles and methods for immunotoxicology testing of medical devices
- GOST R ISO/TS 10993-19-2009 Medical devices. Biological evaluation of medical devices. Part 19. Tests physico-chemical, morphological and topographical characterization of materials
American National Standards Institute (ANSI)
- AAMI/ISO TIR10993-20:2006(R2021) Biological evaluation of medical devices - Part 20: Principles and methods for immunotoxicology testing of medical devices
- ANSI/AAMI BE83-2006 Biological evaluation of medical devices - Part 18: Chemical characterization of materials
- ANSI/AAMI/ISO 10993-11:2017(R2023) Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- AAMI/ISO TIR10993-19:2020 Biological evaluation of medical devices—Part 19: Physico-chemical, morphological and topographical characterization of materials
- ANSI/AAMI/ISO 10993-5:2009(R2022) Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- ANSI/AAMI/ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
AT-ON
- OENORM EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
- OENORM EN ISO 10993-18/A1:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020/DAM 1:2021) (Amendment)
PL-PKN
- PN-EN ISO 10993-18-2020-11 E Biological evaluation of medical devices -- Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
- PN-EN ISO 10993-23-2021-08 E Biological evaluation of medical devices -- Part 23: Tests for irritation (ISO 10993-23:2021)
CH-SNV
- SN EN ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
GOSTR
- GOST ISO/TR 10993-22-2020 Medical devices. Biological evaluation of medical devices. Part 22. Guidance on nanomaterials
- GOST R EN 13612-2010 Performance evaluation of in vitro diagnostic medical devices
- GOST ISO 10993-4-2020 Medical devices. Biological evaluation of medical devices. Part 4. Selection of tests for interactions with blood
- GOST ISO/TR 10993-33-2018 Medical levices. Biological evaluation of medical devices. Part 33. Guidance on tests to evaluate genotoxicity. Supplement to ISO 10993-3
- GOST ISO 10993-3-2018 Medical levices. Biological evaluation of medical devices. Part 3. Tests for genotoxicity, carcinogenicity and reproductive toxicit
- GOST R ISO 10993-2-2009 Standardization in the Russian Federation. Medical devices. Biological evaluation of medical devices. Part 2. Animal welfare requirements
- GOST R ISO 7405-2011 Dentistry. Evaluation of biocompatibility of medical devices used in dentistry
AENOR
- UNE-EN ISO 10993-18:2009 Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005)
- UNE-EN 13612:2002 Performance evaluation of in vitro diagnostic medical devices.
- UNE-EN ISO 10993-13:2010 Biological evaluation of medical devices - Part 13: Identification and quantification of degradation products from polymeric medical devices (ISO 10993-13:2010)
Danish Standards Foundation
- DS/ISO 10993-23:2021 Biological evaluation of medical devices – Part 23: Tests for irritation
- DS/ISO/TR 10993-22:2021 Biological evaluation of medical devices – Part 22: Guidance on nanomaterials
- DS/ISO/TS 37137-1:2021 Biological evaluation of absorbable medical devices – Part 1: General requirements
Canadian Standards Association (CSA)
- CSA ISO-10993.2-97-CAN/CSA:1997 Biological Evaluation of Medical Devices - Part 2: Animal Protection Requirements
ES-UNE
- UNE-EN ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021)
- UNE-EN 13612/AC:2003 Performance evaluation of in vitro diagnostic medical devices.
- UNE-EN ISO 10993-18:2021 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020)
- UNE-EN ISO 10993-11:2018 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017)
- UNE-EN ISO 10993-12:2022 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021)
US-AAMI
- ANSI/AAMI/ISO TIR15499:2012 Biological evaluation of medical devices - Guideance on the conduct of biological evaluation within a risk management process
- ANSI/AAMI/ISO 10993-1:2009 Biological evaluation of medical devices - Part 1:Evaluation and testing within a risk management process
PH-BPS
- PNS ISO 10993-11:2021 Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
- PNS ISO 10993-2:2021 Biological evaluation of medical devices - Part 2: Animal welfare requirements
Non-clinical evaluation of medical devices,,Evaluation of Experimental Chemicals,Chemical Evaluation of Medical Devices,Non-clinical evaluation of medical devices,Clinical Evaluation of Medical Devices,Biological Evaluation of Medical Devices,Biological Evaluation of Medical Devices,Biological Evaluation of Medical Devices Part 4,Medical Device Evaluation,Clinical Evaluation of Medical Devices,chemical evaluation method,Biological Evaluation of Medical Devices Part 8,chemical evaluation method,Medical Device Evaluation,Clinical Evaluation of Medical Devices,Biological Evaluation Chemical Characterization of Materials,Geochemical Evaluation of Land Quality,Medical Device Biological Evaluation,Ethylene Oxide Residues in Biological Evaluation of Medical Devices,Medical Device Chemistry